-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Pulmonx, Lowers Price Target to $4.15

Benzinga·05/22/2025 17:37:13
Listen to the news
Citigroup analyst Joanne Wuensch maintains Pulmonx (NASDAQ:LUNG) with a Neutral and lowers the price target from $6.5 to $4.15.